⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 1, 2004The American Journal of Gastroenterology

Adefovir Dipivoxil to Prevent Exacerbation of Lamivudine-resistant Hepatitis B Infection during Chemotherapy for Non-Hodgkin's Lymphoma

View Full Paper

Ask AI

Bookmark

Share

Abstract

Enomoto, Masaru M.D.; Nishiguchi, Shuhei M.D.; Seki, Shuichi M.D.; Yamane, Takahisa M.D.; Hino, Masayuki M.D. Author Information

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Enomoto et al. (2004) studied this question.

synapsesocial.com/papers/6a8579624f2eb4dbc91e5c6c https://doi.org/10.1111/j.1572-0241.2004.40012.x

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1Long-term therapy of chronic hepatitis B with lamivudineOriginal Research · 2000 · 350 citations
2Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis BRCT · 2003 · 1,002 citations
3Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infectionOriginal Research · 1999 · 89 citations
4Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis BRCT · 2003 · 1,344 citations